PMID- 29044551
OWN - NLM
STAT- MEDLINE
DCOM- 20190517
LR  - 20221207
IS  - 1749-6632 (Electronic)
IS  - 0077-8923 (Print)
IS  - 0077-8923 (Linking)
VI  - 1411
IP  - 1
DP  - 2018 Jan
TI  - Disordered eating and obesity: associations between binge-eating disorder, 
      night-eating syndrome, and weight-related comorbidities.
PG  - 96-105
LID - 10.1111/nyas.13467 [doi]
AB  - Binge-eating disorder (BED) and night-eating syndrome (NES) are two forms of 
      disordered eating associated with overweight and obesity. While these disorders 
      also occur in nonobese persons, they seem to be associated with weight gain over 
      time and higher risk of diabetes and other metabolic dysfunction. BED and NES are 
      also associated with higher risk of psychopathology, including mood, anxiety, and 
      sleep problems, than those of similar weight status without disordered eating. 
      Treatments are available, including cognitive behavior therapy (CBT), 
      interpersonal psychotherapy, lisdexamfetamine, and selective serotonin reuptake 
      inhibitors (SSRIs) for BED; and CBT, SSRIs, progressive muscle relaxation, and 
      bright light therapy for NES.
CI  - (c) 2017 New York Academy of Sciences.
FAU - McCuen-Wurst, Courtney
AU  - McCuen-Wurst C
AD  - Department of Psychiatry, Perelman School of Medicine at the University of 
      Pennsylvania, Philadelphia, Pennsylvania.
FAU - Ruggieri, Madelyn
AU  - Ruggieri M
AD  - Department of Psychiatry, Perelman School of Medicine at the University of 
      Pennsylvania, Philadelphia, Pennsylvania.
FAU - Allison, Kelly C
AU  - Allison KC
AD  - Department of Psychiatry, Perelman School of Medicine at the University of 
      Pennsylvania, Philadelphia, Pennsylvania.
LA  - eng
GR  - R01 DK108628/DK/NIDDK NIH HHS/United States
GR  - R01 DK117488/DK/NIDDK NIH HHS/United States
GR  - R21 DK100787/DK/NIDDK NIH HHS/United States
PT  - Journal Article
PT  - Review
DEP - 20171016
PL  - United States
TA  - Ann N Y Acad Sci
JT  - Annals of the New York Academy of Sciences
JID - 7506858
RN  - 0 (Antidepressive Agents)
RN  - 0 (Serotonin Uptake Inhibitors)
RN  - 333DO1RDJY (Serotonin)
RN  - SJT761GEGS (Lisdexamfetamine Dimesylate)
RN  - WI4X0X7BPJ (Hydrocortisone)
SB  - IM
MH  - Antidepressive Agents/therapeutic use
MH  - Anxiety Disorders/complications/therapy
MH  - Binge-Eating Disorder/*complications/epidemiology/psychology/therapy
MH  - Clinical Trials as Topic
MH  - Comorbidity
MH  - Feeding Behavior
MH  - Female
MH  - Humans
MH  - Hydrocortisone/physiology
MH  - Lisdexamfetamine Dimesylate/therapeutic use
MH  - Male
MH  - Metabolic Syndrome/complications/physiopathology
MH  - Models, Psychological
MH  - Mood Disorders/complications/therapy
MH  - Night Eating Syndrome/*complications/epidemiology/psychology/therapy
MH  - Obesity/*etiology/physiopathology/prevention & control
MH  - Phototherapy
MH  - Prevalence
MH  - Psychotherapy
MH  - Relaxation Therapy
MH  - Serotonin/physiology
MH  - Selective Serotonin Reuptake Inhibitors/therapeutic use
MH  - Sex Distribution
MH  - Sleep Wake Disorders/complications/therapy
MH  - Stress, Psychological/complications/physiopathology
PMC - PMC5788730
MID - NIHMS901795
OTO - NOTNLM
OT  - SSRI
OT  - binge-eating disorder
OT  - cognitive behavior therapy
OT  - metabolic syndrome
OT  - night-eating syndrome
COIS- Competing interests The authors declare no competing interests
EDAT- 2017/10/19 06:00
MHDA- 2019/05/18 06:00
PMCR- 2019/01/01
CRDT- 2017/10/19 06:00
PHST- 2017/05/30 00:00 [received]
PHST- 2017/08/04 00:00 [revised]
PHST- 2017/08/14 00:00 [accepted]
PHST- 2017/10/19 06:00 [pubmed]
PHST- 2019/05/18 06:00 [medline]
PHST- 2017/10/19 06:00 [entrez]
PHST- 2019/01/01 00:00 [pmc-release]
AID - 10.1111/nyas.13467 [doi]
PST - ppublish
SO  - Ann N Y Acad Sci. 2018 Jan;1411(1):96-105. doi: 10.1111/nyas.13467. Epub 2017 Oct 
      16.